TY  - JOUR
AU  - Pedraza-Arevalo, Sergio
AU  - Ibañez-Costa, Alejandro
AU  - Blazquez-Encinas, Ricardo
AU  - Branco, Miguel R
AU  - Vazquez-Borrego, Mari C
AU  - Herrera-Martinez, Aura D
AU  - Venegas-Moreno, Eva
AU  - Serrano-Blanch, Raquel
AU  - Arjona-Sanchez, Alvaro
AU  - Galvez-Moreno, Maria A
AU  - Korbonits, Marta
AU  - Soto-Moreno, Alfonso
AU  - Gahete, Manuel D
AU  - Charalambous, Marika
AU  - Luque, Raúl M
AU  - Castaño, Justo P
PY  - 2021
DO  - 10.1002/1878-0261.13107
UR  - http://hdl.handle.net/10668/22383
T2  - Molecular oncology
AB  - Somatostatin receptor subtype 5 (SST5 ) is an emerging biomarker and actionable target in pituitary (PitNETs) and pancreatic (PanNETs) neuroendocrine tumors. Transcriptional and epigenetic regulation of SSTR5 gene expression and mRNA biogenesis is...
LA  - en
PB  - John Wiley & Sons
KW  - SST5
KW  - Epigenetics
KW  - Natural antisense transcript
KW  - Neuroendocrine tumors
KW  - Pancreas
KW  - Pituitary
KW  - DNA methylation
KW  - Epigenesis, genetic
KW  - Humans
KW  - Neuroendocrine tumors
KW  - Pancreatic neoplasms
KW  - Pituitary neoplasms
KW  - Receptors, somatostatin
TI  - Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST5 ) in pituitary and pancreatic neuroendocrine tumors.
TY  - Research article
VL  - 16
ER  -